Avidity Biosciences
RNAM
#1775
Rank
$11.24 B
Marketcap
$72.82
Share price
0.00%
Change (1 day)
138.91%
Change (1 year)

Avidity Biosciences (RNAM) Fails to deliver data

Key failure to deliver metrics for Avidity Biosciences:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Avidity Biosciences (RNAM) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Avidity Biosciences (RNAM) - since 2020

Volume in USD (price x number of shares), data since 2020

Avidity Biosciences (RNAM) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026$0.74 M-98.48%
2025$49.36 M206.29%
2024$16.11 M267.16%
2023$4.38 M-91.34%
2022$50.7 M162.44%
2021$19.31 M-77.68%
2020$86.53 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
$45.02 M$0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$28.21 M$0.27 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
$4.82 M$23.17 M๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
$13.79 M$18.9 M๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
$0.03 M$1.29 M๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
N/A$0.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
$0.43 M$0.94 M๐Ÿ‡บ๐Ÿ‡ธ USA